Chattem second quarter sales up 28.7% to $39.2 mil., led by Gold Bond, Herpecin-L .
This article was originally published in The Tan Sheet
CHATTEM SECOND QUARTER SALES ADVANCE 29% TO $39.2 MIL. for the period ended May 31. The company continued to attribute its sales growth primarily to the Gold Bond body powder and cream line and Herpecin-L cold sore lip balm, which were acquired in April and June of 1996, respectively. Sales also were boosted by the relaunch of the company's Cornsilk cosmetics line in new packaging and by growth in existing brands including Flexall, Icy Hot, Pamprin and Premsyn PMS
You may also be interested in...
Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty
The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.